BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2205309)

  • 1. RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.
    Hirsch-Ginsberg C; LeMaistre AC; Kantarjian H; Talpaz M; Cork A; Freireich EJ; Trujillo JM; Lee MS; Stass SA
    Blood; 1990 Sep; 76(6):1214-9. PubMed ID: 2205309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
    Kantarjian HM; Shtalrid M; Kurzrock R; Blick M; Dalton WT; LeMaistre A; Stass SA; McCredie KB; Gutterman J; Freireich EJ
    Am J Med; 1988 Nov; 85(5):639-44. PubMed ID: 3189367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.
    Martiat P; Michaux JL; Rodhain J
    Blood; 1991 Jul; 78(1):205-11. PubMed ID: 2070054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.
    Cogswell PC; Morgan R; Dunn M; Neubauer A; Nelson P; Poland-Johnston NK; Sandberg AA; Liu E
    Blood; 1989 Dec; 74(8):2629-33. PubMed ID: 2684296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.
    Cortes JE; Talpaz M; Beran M; O'Brien SM; Rios MB; Stass S; Kantarjian HM
    Cancer; 1995 Jan; 75(2):464-70. PubMed ID: 7812917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
    Kunieda Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
    Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
    Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
    Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
    Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missing Y chromosome in Ph1-negative chronic myeloid leukemia with bcr rearrangement. Evidence for a bcr-abl recombination on chromosome 22 by in situ hybridization.
    Uike N; Inazawa J; Nishigaki H; Takahira H; Katsuno M; Hashimoto M; Kozuru M
    Acta Haematol; 1991; 85(1):51-5. PubMed ID: 2011934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
    Kvasnicka HM
    Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcr rearrangement and C-abl gene expression in Ph1-positive hybrid acute leukemia with simultaneous proliferation of lymphoid and myeloid blasts.
    Okabe M; Oita M; Kunieda Y; Matsuura J; Sakurada K; Matsushima S; Kakinuma M; Miyazaki T
    Blut; 1989 May; 58(5):241-6. PubMed ID: 2655744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.
    Wiedemann LM; Karhi KK; Shivji MK; Rayter SI; Pegram SM; Dowden G; Bevan D; Will A; Galton DA; Chan LC
    Blood; 1988 Feb; 71(2):349-55. PubMed ID: 3276362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia.
    Abeliovich D; Yehuda O; Krichevsky S; Nagler A; Ben-Neriah S; Werner M; Ludkovsky O; Ben-Yehuda D
    Cancer Genet Cytogenet; 1995 Jun; 81(2):115-7. PubMed ID: 7621406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR rearrangement-negative chronic myelogenous leukemia revisited.
    Kurzrock R; Bueso-Ramos CE; Kantarjian H; Freireich E; Tucker SL; Siciliano M; Pilat S; Talpaz M
    J Clin Oncol; 2001 Jun; 19(11):2915-26. PubMed ID: 11387365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation.
    Chen SJ; Chen Z; Font MP; d'Auriol L; Larsen CJ; Berger R
    Nucleic Acids Res; 1989 Oct; 17(19):7631-42. PubMed ID: 2678002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
    Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T
    Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.
    Brunel V; Sainty D; Costello R; Mozziconacci MJ; Simonetti J; Arnoulet C; Coignet L; Bouabdallah R; Gastaut JA; Gabert J
    Cancer Genet Cytogenet; 1995 Nov; 85(1):82-4. PubMed ID: 8536245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.